Khairy H Morsy, et al. “Can Eicosapentaenoic Acid Maintain the Original Ribavirin Dose or Affect the Response During the Treatment Course of Chronic Hepatitis C Virus (HCV) Patients?”. Turkish Journal of Gastroenterology, vol. 27, no. 1, July 2019, pp. 55-61, https://tjg.avesjournals.com/index.php/tjg/article/view/3219.